16-1201821-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_021098.3(CACNA1H):c.1371C>T(p.Tyr457Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000567 in 1,581,512 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00054 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00057 ( 6 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0760
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 16-1201821-C-T is Benign according to our data. Variant chr16-1201821-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 529671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.076 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000545 (83/152356) while in subpopulation SAS AF = 0.00104 (5/4830). AF 95% confidence interval is 0.000469. There are 0 homozygotes in GnomAd4. There are 41 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 83 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.1332C>T | p.Tyr444Tyr | synonymous_variant | Exon 9 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.1332C>T | p.Tyr444Tyr | synonymous_variant | Exon 9 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.1371C>T | p.Tyr457Tyr | synonymous_variant | Exon 9 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*818C>T | non_coding_transcript_exon_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.1371C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*818C>T | 3_prime_UTR_variant | Exon 8 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000545 AC: 83AN: 152238Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
83
AN:
152238
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000867 AC: 169AN: 195028 AF XY: 0.000902 show subpopulations
GnomAD2 exomes
AF:
AC:
169
AN:
195028
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000570 AC: 814AN: 1429156Hom.: 6 Cov.: 36 AF XY: 0.000599 AC XY: 424AN XY: 707872 show subpopulations
GnomAD4 exome
AF:
AC:
814
AN:
1429156
Hom.:
Cov.:
36
AF XY:
AC XY:
424
AN XY:
707872
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32776
American (AMR)
AF:
AC:
2
AN:
39588
Ashkenazi Jewish (ASJ)
AF:
AC:
322
AN:
25504
East Asian (EAS)
AF:
AC:
0
AN:
37982
South Asian (SAS)
AF:
AC:
44
AN:
81858
European-Finnish (FIN)
AF:
AC:
1
AN:
49844
Middle Eastern (MID)
AF:
AC:
7
AN:
5614
European-Non Finnish (NFE)
AF:
AC:
375
AN:
1096684
Other (OTH)
AF:
AC:
61
AN:
59306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000545 AC: 83AN: 152356Hom.: 0 Cov.: 34 AF XY: 0.000550 AC XY: 41AN XY: 74502 show subpopulations
GnomAD4 genome
AF:
AC:
83
AN:
152356
Hom.:
Cov.:
34
AF XY:
AC XY:
41
AN XY:
74502
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41592
American (AMR)
AF:
AC:
1
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
33
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
5
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42
AN:
68018
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Dec 04, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Sep 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.